退伍军人事务医疗系统中直接口服抗凝药治疗急性肺栓塞的结局:一项回顾性队列研究
该回顾性队列研究纳入2015至2024年美国退伍军人事务医疗系统中在急诊诊断急性肺栓塞并在1天内接受DOAC治疗的成人患者,共6427例首次急性肺栓塞。按sPESI分层,30天全因死亡率分别为sPESI 0:0.0%、1:0.4%、2:1.8%、3:3.8%、4:8.8%、5:21.1%、6:25.0%。在3799例sPESI<2的患者中,2578例(67.9%)住院,中位住院时间24小时;校正协变量后,住院与急诊离院的30天全因死亡 odds 相似(OR 1.32,95%CI 0.40-4.36,p=0.65)。作者认为这些发现支持扩大急性肺栓塞的门诊管理,并在无其他住院指征时减少短期低价值住院。
要点
- sPESI 0或1的急性肺栓塞患者接受DOAC治疗后30天全因死亡率极低(0.0%和0.4%)。
- sPESI<2的患者中67.9%住院,中位住院时间仅24小时。
- 校正协变量后,住院与急诊离院的30天全因死亡 odds 相似(OR 1.32,95%CI 0.40-4.36,p=0.65)。
- 作者认为这些发现支持扩大急性肺栓塞的门诊管理,并在无其他住院指征时减少短期低价值住院。
适用人群与场景
- 美国退伍军人事务医疗系统急诊诊断的成人急性肺栓塞患者,且在诊断后1天内接受DOAC治疗。
研究设计与关键结果
- 研究类型:回顾性队列研究;样本量:6427例首次急性肺栓塞;人群:美国退伍军人事务医疗系统2015至2024年急诊诊断的成人急性肺栓塞患者,且在1天内接受DOAC治疗;暴露:住院 vs 急诊离院;主要终点:30天全因死亡率。
- 30天全因死亡率按sPESI分层:sPESI 0为0.0%,sPESI 1为0.4%,sPESI 2为1.8%,sPESI 3为3.8%,sPESI 4为8.8%,sPESI 5为21.1%,sPESI 6为25.0%。
- sPESI<2的患者共3799例,其中2578例(67.9%)住院,中位住院时间24小时。
- 校正协变量后,住院与急诊离院的30天全因死亡 odds 相似(OR 1.32,95%CI 0.40-4.36,p=0.65)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为这些发现支持扩大急性肺栓塞的门诊管理,并在无其他住院指征时减少短期低价值住院。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Although guidelines support outpatient management for low-risk pulmonary embolism, U.S. emergency department (ED) adoption remains low, partly due to limited contemporary evidence. Direct oral anticoagulant (DOAC) era studies are small or European and typically classify all sPESI > 0 as high risk. More granular U.S. outcomes are needed to inform which patients can be safely discharged.
OBJECTIVES: To characterize 30-day all-cause mortality by sPESI in patients with an acute PE treated with a DOAC.
DESIGN: Retrospective cohort study.
SETTING: United States Veterans Affairs (VA) Health System, 2015 to 2024.
PARTICIPANTS: Adult patients diagnosed with an acute PE in a VA ED were prescribed a DOAC within one day.
EXPOSURE: Hospital admission.
MAIN OUTCOMES: 30-day all-cause mortality.
RESULTS: A total of 6,427 first-time acute PEs were treated with a DOAC. Thirty-day mortality rates by sPESI were: sPESI 0: 0.0%, sPESI 1: 0.4%, sPESI 2: 1.8%, sPESI 3: 3.8%, sPESI 4: 8.8%, sPESI 5: 21.1%, and sPESI 6: 25.0%. Of 3,799 patients with sPESI < 2, 2,578 (67.9%) were hospitalized with a median length of stay of 24 h. After adjusting for covariates, odds of 30-day all-cause mortality were similar regardless of admission vs. ED discharge (OR 1.32, 95% CI 0.40, 4.36, p = 0.65).
CONCLUSIONS: In this large U.S. DOAC-era cohort, patients with sPESI 0 or 1 had very low 30-day mortality, and hospitalization did not appear to improve outcomes. Despite this, two-thirds were admitted. These findings support expanding outpatient management of acute PE and reducing short-stay, low-value hospitalizations if no other indication for admission exists.
参考来源
- Dore M, Duffy R. Outcomes of Acute PE Treated With DOACs in the Veterans Affairs Health System: A Retrospective Cohort Study. Acad Emerg Med. 2026. PMID: 42313763. doi:10.1111/acem.70360
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。